11 Sep 2017 | Business Wire
Sales of $4.8 million in the quarter were 80 per cent higher than in the comparable period of the prior year and were 29 per cent higher than the second quarter of 2017.
11 Aug 2017 | Insurance Business
Companies need to start thinking about the therapeutic benefits
9 Aug 2017 | Benzinga
GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) shares initially jumped Monday after disappointing data from a leading drug candidate sent shares of Zynerba Pharmaceuticals Inc
8 Aug 2017 | Finfeed.com
The Swiss launch of CPH’s proprietary formulated hemp-based complementary feed products for companion animals, anibidiol® 1.25 and anibidiol® 2.5, is planned for the fourth quarter of this year.
8 Aug 2017 | Streetwise Reports
A preclinical research and development company that is developing a proprietary cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury, has just completed a reverse takeover.
1 Aug 2017 | Wealth Management
Investors looking to take a flyer on the “budding” industry need to understand that risks go up when companies “touch the plant.” Safer plays are further down the supply chain.
1 Aug 2017 | Finance News Network
Executive Chairman and Co-Founder Boaz Wachtel and Chief Operating Officer David Russell talk about the strategic advantages and plans for Canadian-based Mernova Medicinal.
31 Jul 2017 | CannaTech News
As medical cannabis takes off around the world, Avicanna is the latest company to join the big boys in a very special innovation
30 Jul 2017 | The Motley Fool
Both of these fledgling drugmakers have cannabinoids in their pipelines, but they're far more attractive than your average marijuana stock. Find out which one stands tallest when stacked side by side.
28 Jul 2017 | The Market Mogul
Drug policy usually moves like an iceberg: slowly. And while and it can be hard to turn, sometimes it changes course in an unexpected direction.